{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:30:21Z","timestamp":1794238221680,"version":"4.9.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>In SSc patients, disease specific determinants that influence health-related quality of life (HRQoL) over time have not been described. We aim to, in patients with SSc, (i) evaluate if and how HRQoL changes over time, and (ii) assess how different SSc domains and functional impairments contribute to changes in HRQoL over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>All SSc patients from the Leiden SSc cohort were included; patients with disease duration &amp;lt;24\u2009months were classified as incident cases. HRQoL was assessed prospectively on an annual basis using the EQ-5D and the SF36. To assess baseline associations between clinical characteristics and HRQoL, linear regressions were performed. To identify possible associations between SSc characteristics and HRQoL change over time, linear mixed models were performed in both incident and prevalent cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 492 SSc patients were included (n\u2009=\u2009202 incident cases), with a median follow-up duration of 3.4\u2009years. At baseline, presence of organ involvement was independently associated with a worse SF36 physical component score and lower EQ-5D score. Over time, gastrointestinal symptoms, Raynaud and digital ulcers were independently associated with deterioration of HRQoL in both incident and prevalent cases. In prevalent cases, pulmonary arterial hypertension (PAH) was associated with a decrease in HRQoL over time. Worse functioning as measured by six-min walking distance, mouth-opening, finger-to-palm distance and grip-strength contributed significantly to deterioration of HRQoL over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In SSc, key clinical burdens that contribute to worsening of HRQoL over time include digital ulcers, Raynaud and gastrointestinal involvement. In addition, PAH is a significant burden in prevalent disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa827","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T21:23:08Z","timestamp":1605820988000},"source":"Crossref","is-referenced-by-count":56,"title":["Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants"],"prefix":"10.1093","author":[{"given":"Nina M","family":"van Leeuwen","sequence":"first","affiliation":[{"name":"Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Ciaffi","sequence":"additional","affiliation":[{"name":"Medicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli (IOR), Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie I E","family":"Liem","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W J","family":"Huizinga","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeska K","family":"de Vries-Bouwstra","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"2021010516504356800_keaa827-B1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"NEJM"},{"key":"2021010516504356800_keaa827-B2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"2021010516504356800_keaa827-B3","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/rheumatology\/keh671","article-title":"Classification of systemic sclerosis. Visions and reality","volume":"44","author":"Wollheim","year":"2005","journal-title":"Rheumatology"},{"key":"2021010516504356800_keaa827-B4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3899\/jrheum.080281","article-title":"Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions","volume":"36","author":"Hudson","year":"2009","journal-title":"J Rheumatol"},{"key":"2021010516504356800_keaa827-B5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13075-019-1842-x","article-title":"Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study","volume":"21","author":"Park","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2021010516504356800_keaa827-B6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.31887\/DCNS.2014.16.2\/mbullinger","article-title":"Quality of life as patient-reported outcomes: principles of assessment","volume":"16","author":"Bullinger","year":"2014","journal-title":"Dialogues Clin Neurosci"},{"key":"2021010516504356800_keaa827-B7","first-page":"w14394","article-title":"Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis","volume":"146","author":"Gualtierotti","year":"2016","journal-title":"Swiss Med Wkly"},{"key":"2021010516504356800_keaa827-B8","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/1756-185X.13438","article-title":"The impact of systemic sclerosis on health-related quality of life assessed by SF-36: a systematic review and meta-analysis","volume":"21","author":"Li","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2021010516504356800_keaa827-B9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2016.02.005","article-title":"Impaired quality of life in systemic sclerosis and patient perception of the disease: a large international survey","volume":"46","author":"Frantz","year":"2016","journal-title":"Semin. Arthritis Rheum"},{"key":"2021010516504356800_keaa827-B10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/kel189","article-title":"Impact of pain in health related quality of life of patients with systemic sclerosis","volume":"45","author":"Georges","year":"2006","journal-title":"Rheumatology"},{"key":"2021010516504356800_keaa827-B11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/ard.2007.075721","article-title":"The relationship of dyspnoea to function and quality of life in systemic sclerosis","volume":"67","author":"Baron","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021010516504356800_keaa827-B12","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/annrheumdis-2015-208121","article-title":"Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry","volume":"75","author":"Matucci-Cerinic","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021010516504356800_keaa827-B13","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/art.22580","article-title":"Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study","volume":"56","author":"Khanna","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021010516504356800_keaa827-B14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kel038","article-title":"Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol","volume":"45","author":"Milio","year":"2006","journal-title":"Rheumatology"},{"key":"2021010516504356800_keaa827-B15","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021010516504356800_keaa827-B16","doi-asserted-by":"crossref","first-page":"e000159","DOI":"10.1136\/rmdopen-2015-000159","article-title":"Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis","volume":"2","author":"Meijs","year":"2016","journal-title":"RMD Open"},{"key":"2021010516504356800_keaa827-B17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3899\/jrheum.090375","article-title":"The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma","volume":"37","author":"Sekhon","year":"2010","journal-title":"J Rheumatol"},{"key":"2021010516504356800_keaa827-B18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jval.2013.10.006","article-title":"From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire","volume":"17","author":"Rabin","year":"2014","journal-title":"Value Health"},{"key":"2021010516504356800_keaa827-B19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hec.1124","article-title":"The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies","volume":"15","author":"Lamers","year":"2006","journal-title":"Health Econ"},{"key":"2021010516504356800_keaa827-B20","first-page":"50","article-title":"A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis","volume":"31","author":"Kwakkenbos","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2021010516504356800_keaa827-B21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.acvd.2009.06.009","article-title":"Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies","volume":"103","author":"Meune","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"2021010516504356800_keaa827-B22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.24730","article-title":"Reliability and validity of the University of California, Los Angeles Scleroderma clinical trial consortium gastrointestinal tract instrument","volume":"61","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021010516504356800_keaa827-B23","first-page":"S-41","article-title":"Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch","volume":"32","author":"Meijs","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2021010516504356800_keaa827-B24","first-page":"69","article-title":"Grip and pinch strength: normative data for adults","volume":"66","author":"Mathiowetz","year":"1985","journal-title":"Arch Phys Med Rehabil"},{"key":"2021010516504356800_keaa827-B25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jht.2017.10.013","article-title":"The evaluation of a home-based program for hands in patients with systemic sclerosis","volume":"32","author":"Landim","year":"2019","journal-title":"J Hand Ther"},{"key":"2021010516504356800_keaa827-B26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000502643","article-title":"Effect of impairment-oriented and function-oriented exercises on mouth function in subjects with systemic sclerosis","volume":"72","author":"Vitali","year":"2020","journal-title":"Folia Phonatr LogoP"},{"key":"2021010516504356800_keaa827-B27","first-page":"161","article-title":"Usefulness of six-minute walk test in systemic sclerosis","volume":"36","author":"Rizzi","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2021010516504356800_keaa827-B28","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.1780401110","article-title":"The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2021010516504356800_keaa827-B29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/msc.223","article-title":"The association of illness perceptions with physical and mental health in systemic sclerosis patients: an exploratory study","volume":"10","author":"Arat","year":"2012","journal-title":"Musculoskeletal Care"},{"key":"2021010516504356800_keaa827-B30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MEG.0b013e32831dac75","article-title":"Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study","volume":"21","author":"Franck-Larsson","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2021010516504356800_keaa827-B31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3899\/jrheum.110826","article-title":"Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis","volume":"39","author":"Omair","year":"2012","journal-title":"J Rheumatol"},{"key":"2021010516504356800_keaa827-B32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/rheumatology\/key026","article-title":"The patient experience of Raynaud's phenomenon in systemic sclerosis","volume":"58","author":"Pauling","year":"2019","journal-title":"Rheumatology"},{"key":"2021010516504356800_keaa827-B33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00296-016-3636-7","article-title":"Interstitial lung disease in systemic sclerosis: current and future treatment","volume":"37","author":"Giacomelli","year":"2017","journal-title":"Rheumatol Int"},{"key":"2021010516504356800_keaa827-B34","first-page":"122","article-title":"Evaluation of quality of life in patients with systemic sclerosis by administering the SF-36 questionnaire","volume":"54","author":"Cossutta","year":"2002","journal-title":"Reumatismo"},{"key":"2021010516504356800_keaa827-B35","first-page":"832","article-title":"Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial","volume":"32","author":"Khanna","year":"2005","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa827\/35433377\/keaa827.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaa827\/35433377\/keaa827.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T07:30:20Z","timestamp":1610263820000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article\/doi\/10.1093\/rheumatology\/keaa827\/6064847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa827","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"article-number":"keaa827"}}